Esperion Therapeutics stock remains a buy as strong drug franchises, growth, and global milestones outweigh risks. Learn more ...

BIDU heads into Q3 with rising AI and autonomous momentum but faces softer advertising trends and heavier investment pressure.

Celsia SA Esp (BOG:CELSIA) reports a remarkable 173% revenue growth, strategic partnerships, and global expansion, despite facing integration challenges.

WPP India's CVL Srinivas conferred with Lifetime Achievement Award; Prasanth Kumar, Navin Khemka, Atul Hegde, among other key ...

As investors await upcoming earnings reports, the performance of key players within the Retail-Wholesale sector could impact ...

The TJX Companies' third-quarter results are likely to reflect sales momentum and customer growth amid pressure from higher ...

While FDA reviews PMA application for the upcoming Perimeter B-Series (Company continues to anticipate Agency's decision in H1-2026) , commercial market ...

While FDA reviews PMA application for the upcoming Perimeter B-Series (Company continues to anticipate Agency's decision in H1-2026), commercial market traction with ...

NVIDIA Corporation NVDA is likely to beat on earnings when it reports third-quarter fiscal 2026 results on Nov. 19, after market close. The company expects revenues of $54 billion (+/-2%) for the ...